e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis
Devouassoux G., Cottin V., Liote H., Marchand E., Frachon I., Schuller A., Bejui-Thivolet F., Cordier J-F., the Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P)
Source:
Eur Respir J 2009; 33: 1053-1061
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Devouassoux G., Cottin V., Liote H., Marchand E., Frachon I., Schuller A., Bejui-Thivolet F., Cordier J-F., the Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J 2009; 33: 1053-1061
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome
Source: Eur Respir J 2011; 37: 1411-1417
Year: 2011
Bronchiectasis associated with inflammatory bowel disease
Source: Eur Respir Mon 2011; 52: 163-177
Year: 2011
Disease of the airways in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 41S-49S
Year: 2001
Small airways diseases, excluding asthma and COPD: an overview
Source: Eur Respir Rev 2013; 22: 131-147
Year: 2013
Pathology of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159
Year: 2006
Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Destructive bronchiolitis: a characteristic pathological feature of interstitial lung disease preceding the onset of rheumatoid arthritis
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Definition and differential diagnosis of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1
Year: 2006
Airway pathology in asthma
Source: Eur Respir J 2001; 18: 18S-23S
Year: 2001
Pathology of pulmonary involvement in inflammatory bowel disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=199
Year: 2007
Medicines used in respiratory diseases only seen in children
Source: Eur Respir J 2009; 34: 531
Year: 2009
Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Source: Eur Respir J 2007; 29: 906-913
Year: 2007
Fibrosing alveolitis in rheumatoid arthritis (FARA):a survival comparison with idiopathic usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP)
Source: Eur Respir J 2003; 22: Suppl. 45, 197s
Year: 2003
Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003
Alveolar remodelling in COPD
Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease
Year: 2006
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
Source: Eur Respir J 2006; 27: 293-299
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept